Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled vs Intravenous Milrinone in Mitral Valve Surgery
NCT01621971Phase 3Completed
- Sponsor
- Konkuk University Medical Center
- Start
- Jan 2003
- Primary completion
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of milrinone in pulmonary hypertension (PH) and mitral regurgitation (MR) (2 arms), sponsored by Konkuk University Medical Center. Primary endpoint: Transpulmonary Pressure Gradient. Started Jan 2003; status: completed.
02
Drugs
milrinone
03
Conditions
pulmonary hypertension (PH)mitral regurgitation (MR)
Beyond the preview
Go deeper on NCT01621971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01621971.